MYC and adenocarcinoma: Given the gains of 13q, which includes the miR-17-92 cluster, and gain of 8q, including frequent c-myc amplification, led us to test the hypothesis that gene dosage effects of the miR-17-92 cluster are associated with colorectal adenoma to adenocarcinoma progression.